iBio, Inc.
IBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001420720
No open-market purchases or sales by iBio, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; no superinvestor holds it.
Holders of 5% or more of IBIO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of iBio, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 13G/A | 9.99%5.12M shares | 0.00 ppfrom 9.99% | Nov 14, 20253 filings | Aug 14, 2026 | SEC |
| Affinity Asset Advisors, LLC | 13G/A | 9.99%5.07M shares | 0.00 ppfrom 9.99% | Aug 26, 20255 filings | Aug 13, 2026 | SEC |
| Silverarc Capital Management, LLC | 13G | 9.99%2.18M shares | New | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
| Adage Capital Management, L.P. | 13G | 9.99%2.18M shares | New | Nov 13, 20251 filing | Nov 13, 2025 | SEC |
| Sirenia Capital Management LP | 13G | 9.90%11.6M shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
| Vestal Point Capital, LP | 13G/A | 7.90%4.03M shares | −2.00 ppfrom 9.90% | Nov 14, 20252 filings | Aug 14, 2026 | SEC |
| Opaleye Management Inc. | 13G/A | 7.60%750.0K shares | – | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
| Frazier Life Sciences Public Fund, L.P. | 13G/A | 5.70%1.95M shares | −3.00 ppfrom 8.70% | Dec 16, 20252 filings | May 12, 2026 | SEC |
| Lynx1 Capital Management LP | 13G | 5.40%2.81M shares | +5.40 ppfrom 0.00% | Feb 17, 20262 filings | Aug 14, 2026 | SEC |
| Integrated Core Strategies (US) LLC | 13G | 5.20%1.24M shares | New | Jan 22, 20261 filing | Jan 22, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
34 Schedule 13D and 13G filings on iBio, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20264:31 PM ET | Lynx1 Capital Management LPand 1 other | 13G | 5.40%2.81M shares | +5.40 ppfrom 0.00% | Jun 30, 2026 | SEC |
| Aug 14, 20264:05 PM ET | Vestal Point Capital, LPand 1 other | 13G/A | 7.90%4.03M shares | −2.00 ppfrom 9.90% | Jun 30, 2026 | SEC |
| Aug 14, 20262:03 PM ET | Cormorant Asset Management, LPand 1 other | 13G/A | 9.99%5.12M shares | 0.00 ppfrom 9.99% | Jun 30, 2026 | SEC |
| Aug 13, 20264:05 PM ET | Affinity Asset Advisors, LLCand 1 other | 13G/A | 9.99%5.07M shares | 0.00 ppfrom 9.99% | Jun 30, 2026 | SEC |
| May 15, 20266:42 PM ET | Logos Global Management LPand 4 others | 13G/A | 0.00%0 shares | −4.60 ppfrom 4.60%Below 5% | Mar 31, 2026 | SEC |
| May 15, 20264:19 PM ET | Point72 Asset Management, L.P.and 2 others | 13G/A | 0.00%0 shares | −9.90 ppfrom 9.90%Below 5% | Mar 31, 2026 | SEC |
| May 15, 20262:26 PM ET | EcoR1 Capital, LLCand 2 others | 13G/A | 4.60%1.58M shares | −5.30 ppfrom 9.90%Below 5% | Mar 31, 2026 | SEC |
| May 15, 20261:22 PM ET | Cormorant Asset Management, LPand 1 other | 13G/A | 9.99%3.83M shares | 0.00 ppfrom 9.99% | Mar 31, 2026 | SEC |
| May 15, 20268:16 AM ET | Sirenia Capital Management LPand 1 other | 13G | 9.90%11.6M shares | New | Mar 31, 2026 | SEC |
| May 14, 20264:11 PM ET | Affinity Asset Advisors, LLCand 1 other | 13G/A | 9.99%3.49M shares | 0.00 ppfrom 9.99% | Mar 31, 2026 | SEC |
| May 12, 20264:31 PM ET | Frazier Life Sciences Public Fund, L.P.and 8 others | 13G/A | 5.70%1.95M shares | −3.00 ppfrom 8.70% | Mar 31, 2026 | SEC |
| Feb 17, 20266:20 PM ET | ADAR1 Capital Management, LLCand 3 others | 13G/A | 4.40%1.35M shares | −5.50 ppfrom 9.90%Below 5% | Dec 31, 2025 | SEC |
| Feb 17, 20266:19 PM ET | Logos Global Management LPand 4 others | 13G/A | 4.60%1.50M shares | −4.30 ppfrom 8.90%Below 5% | Dec 31, 2025 | SEC |
| Feb 17, 20261:46 PM ET | Lynx1 Capital Management LPand 1 other | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2025 | SEC |
| Jan 29, 20269:29 PM ET | Affinity Asset Advisors, LLCand 1 other | 13G/A | 9.99%2.40M shares | 0.00 ppfrom 9.99% | Jan 22, 2026 | SEC |
| Jan 22, 20265:02 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G | 5.20%1.24M shares | New | Jan 15, 2026 | SEC |
| Dec 19, 20254:45 PM ET | Logos Global Management LPand 4 others | 13G | 8.90%2.00M shares | New | Dec 12, 2025 | SEC |
| Dec 17, 20255:42 PM ET | EcoR1 Capital, LLCand 2 others | 13G | 9.90%2.23M shares | New | Dec 10, 2025 | SEC |
| Dec 16, 20254:39 PM ET | Frazier Life Sciences Public Fund, L.P.and 2 others | 13G | 8.70%1.95M shares | New | Dec 9, 2025 | SEC |
| Dec 3, 20253:19 PM ET | Affinity Asset Advisors, LLCand 1 other | 13G/A | 9.99%2.18M shares | 0.00 ppfrom 9.99% | Aug 19, 2025 | SEC |
| Nov 14, 20256:28 PM ET | Ikarian Capital, LLCand 1 other | 13G/A | 4.99%1.15M shares | –Below 5% | Sep 30, 2025 | SEC |
| Nov 14, 20254:05 PM ET | Vestal Point Capital, LPand 1 other | 13G | 9.90%4.28M shares | New | Sep 30, 2025 | SEC |
| Nov 14, 20251:11 PM ET | Silverarc Capital Management, LLCand 2 others | 13G | 9.99%2.18M shares | New | Sep 30, 2025 | SEC |
| Nov 14, 20251:07 PM ET | Cormorant Asset Management, LPand 1 other | 13G | 9.99%2.25M shares | New | Sep 30, 2025 | SEC |
| Nov 13, 20259:17 AM ET | Adage Capital Management, L.P.and 2 others | 13G | 9.99%2.18M shares | New | Sep 30, 2025 | SEC |
| Aug 26, 20254:47 PM ET | Affinity Asset Advisors, LLCand 1 other | 13G | 9.99%4.28M shares | New | Aug 19, 2025 | SEC |
| Aug 25, 20255:20 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 9.90%14.3M shares | New | Aug 22, 2025 | SEC |
| Aug 14, 20259:13 PM ET | ADAR1 Capital Management, LLCand 2 others | 13G/A | 9.90%1.79M shares | −0.09 ppfrom 9.99% | Jun 30, 2025 | SEC |
| Jul 30, 20258:40 AM ET | Crutcher Patrick J | 13G/A | 3.10%847.0K shares | −3.90 ppfrom 7.00%Below 5% | Jun 30, 2025 | SEC |
| Feb 14, 20259:10 PM ET | ADAR1 Capital Management, LLCand 2 others | 13G/A | 9.99%1.10M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 20256:42 AM ET | Opaleye Management Inc. | 13G/A | 7.60%750.0K shares | – | Dec 31, 2024 | SEC |
| Jan 30, 20256:38 PM ET | Crutcher Patrick J | 13G/A | 7.00%696.7K shares | −0.20 ppfrom 7.20% | Jan 28, 2025 | SEC |
| Jan 29, 20257:33 PM ET | Crutcher Patrick J | 13G | 7.20%714.7K shares | New | Jan 28, 2025 | SEC |
| Jan 3, 20255:19 PM ET | Sabby Management, LLCand 2 others | 13G/A | 0.20%19.3K shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell iBio, Inc. shares.
No Form 144 notices for iBio, Inc. are on file.